A detailed history of Bank Of America Corp transactions in Vericel Corp stock. As of the latest transaction made, Bank Of America Corp holds 141,369 shares of VCEL stock, worth $8.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
141,369
Previous 136,288 3.73%
Holding current value
$8.31 Million
Previous $6.25 Million 4.48%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.25 - $53.56 $214,672 - $272,138
5,081 Added 3.73%
141,369 $5.97 Million
Q2 2024

Aug 14, 2024

SELL
$41.71 - $52.9 $23,399 - $29,676
-561 Reduced 0.41%
136,288 $6.25 Million
Q1 2024

May 15, 2024

BUY
$32.52 - $52.33 $2.05 Million - $3.29 Million
62,915 Added 85.1%
136,849 $7.12 Million
Q4 2023

Feb 14, 2024

SELL
$30.85 - $37.09 $100,355 - $120,653
-3,253 Reduced 4.21%
73,934 $2.63 Million
Q2 2023

Aug 14, 2023

SELL
$29.0 - $38.37 $3.43 Million - $4.53 Million
-118,133 Reduced 60.48%
77,187 $2.9 Million
Q1 2023

May 12, 2023

BUY
$23.85 - $31.34 $1.82 Million - $2.39 Million
76,204 Added 63.97%
195,320 $5.73 Million
Q4 2022

Feb 10, 2023

BUY
$17.65 - $27.37 $396,418 - $614,730
22,460 Added 23.24%
119,116 $3.14 Million
Q3 2022

Nov 14, 2022

BUY
$22.62 - $32.54 $803,349 - $1.16 Million
35,515 Added 58.09%
96,656 $2.24 Million
Q2 2022

Aug 12, 2022

SELL
$22.88 - $39.45 $191,482 - $330,157
-8,369 Reduced 12.04%
61,141 $1.54 Million
Q1 2022

May 16, 2022

SELL
$31.69 - $43.29 $1.13 Million - $1.54 Million
-35,646 Reduced 33.9%
69,510 $2.66 Million
Q4 2021

Feb 08, 2022

BUY
$35.2 - $52.6 $973,104 - $1.45 Million
27,645 Added 35.67%
105,156 $4.13 Million
Q3 2021

Nov 15, 2021

BUY
$46.35 - $59.75 $471,333 - $607,597
10,169 Added 15.1%
77,511 $3.78 Million
Q2 2021

Sep 13, 2021

BUY
$47.2 - $67.81 $3.18 Million - $4.57 Million
67,342 New
67,342 $3.54 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.77B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.